CERS
Price
$1.37
Change
-$0.00 (-0.00%)
Updated
Apr 23 closing price
Capitalization
342.62M
7 days until earnings call
ICUI
Price
$132.28
Change
+$1.60 (+1.22%)
Updated
Apr 23 closing price
Capitalization
2.55B
18 days until earnings call
Ad is loading...

CERS vs ICUI

Header iconCERS vs ICUI Comparison
Open Charts CERS vs ICUIBanner chart's image
Cerus
Price$1.37
Change-$0.00 (-0.00%)
Volume$1.01M
Capitalization342.62M
ICU Medical
Price$132.28
Change+$1.60 (+1.22%)
Volume$305.93K
Capitalization2.55B
CERS vs ICUI Comparison Chart
Loading...
CERS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ICUI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CERS vs. ICUI commentary
Apr 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CERS is a Buy and ICUI is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 24, 2025
Stock price -- (CERS: $1.37 vs. ICUI: $132.24)
Brand notoriety: CERS and ICUI are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: CERS: 70% vs. ICUI: 96%
Market capitalization -- CERS: $342.62M vs. ICUI: $2.55B
CERS [@Medical Specialties] is valued at $342.62M. ICUI’s [@Medical Specialties] market capitalization is $2.55B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.31B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CERS’s FA Score shows that 0 FA rating(s) are green whileICUI’s FA Score has 1 green FA rating(s).

  • CERS’s FA Score: 0 green, 5 red.
  • ICUI’s FA Score: 1 green, 4 red.
According to our system of comparison, ICUI is a better buy in the long-term than CERS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CERS’s TA Score shows that 5 TA indicator(s) are bullish while ICUI’s TA Score has 3 bullish TA indicator(s).

  • CERS’s TA Score: 5 bullish, 3 bearish.
  • ICUI’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, CERS is a better buy in the short-term than ICUI.

Price Growth

CERS (@Medical Specialties) experienced а +5.38% price change this week, while ICUI (@Medical Specialties) price change was -4.96% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +3.05%. For the same industry, the average monthly price growth was -8.45%, and the average quarterly price growth was -3.85%.

Reported Earning Dates

CERS is expected to report earnings on Jul 31, 2025.

ICUI is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Medical Specialties (+3.05% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ICUI($2.55B) has a higher market cap than CERS($343M). CERS YTD gains are higher at: -11.039 vs. ICUI (-14.777). ICUI has higher annual earnings (EBITDA): 253M vs. CERS (-26.34M). ICUI has more cash in the bank: 255M vs. CERS (65.9M). CERS has less debt than ICUI: CERS (96M) vs ICUI (1.7B). ICUI has higher revenues than CERS: ICUI (2.26B) vs CERS (156M).
CERSICUICERS / ICUI
Capitalization343M2.55B13%
EBITDA-26.34M253M-10%
Gain YTD-11.039-14.77775%
P/E RatioN/A333.33-
Revenue156M2.26B7%
Total Cash65.9M255M26%
Total Debt96M1.7B6%
FUNDAMENTALS RATINGS
CERS vs ICUI: Fundamental Ratings
CERS
ICUI
OUTLOOK RATING
1..100
6062
VALUATION
overvalued / fair valued / undervalued
1..100
43
Fair valued
92
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9491
PRICE GROWTH RATING
1..100
7961
P/E GROWTH RATING
1..100
1002
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CERS's Valuation (43) in the Medical Specialties industry is somewhat better than the same rating for ICUI (92). This means that CERS’s stock grew somewhat faster than ICUI’s over the last 12 months.

CERS's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as ICUI (100). This means that CERS’s stock grew similarly to ICUI’s over the last 12 months.

ICUI's SMR Rating (91) in the Medical Specialties industry is in the same range as CERS (94). This means that ICUI’s stock grew similarly to CERS’s over the last 12 months.

ICUI's Price Growth Rating (61) in the Medical Specialties industry is in the same range as CERS (79). This means that ICUI’s stock grew similarly to CERS’s over the last 12 months.

ICUI's P/E Growth Rating (2) in the Medical Specialties industry is significantly better than the same rating for CERS (100). This means that ICUI’s stock grew significantly faster than CERS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CERSICUI
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
64%
Momentum
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 1 day ago
70%
MACD
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
68%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
77%
Bearish Trend 1 day ago
67%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
65%
Advances
ODDS (%)
Bullish Trend 14 days ago
77%
Bullish Trend 22 days ago
67%
Declines
ODDS (%)
Bearish Trend 9 days ago
83%
Bearish Trend 3 days ago
68%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
75%
Aroon
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 4 days ago
68%
View a ticker or compare two or three
Ad is loading...
CERS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ICUI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RVVHX8.500.09
+1.07%
Royce Small-Cap Value Investment
EPLPX20.220.15
+0.75%
NYLI Epoch U.S. Equity Yield Class A
FBFRX12.03N/A
N/A
Franklin Managed Income R6
AMCFX38.62N/A
N/A
American Funds AMCAP F2
MLPLX5.84N/A
N/A
Invesco SteelPath MLP Alpha Plus A

ICUI and

Correlation & Price change

A.I.dvisor indicates that over the last year, ICUI has been loosely correlated with CLPT. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if ICUI jumps, then CLPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ICUI
1D Price
Change %
ICUI100%
+1.19%
CLPT - ICUI
52%
Loosely correlated
+3.52%
ALGN - ICUI
47%
Loosely correlated
+1.93%
NVST - ICUI
46%
Loosely correlated
+3.63%
VCYT - ICUI
46%
Loosely correlated
+1.08%
HBIO - ICUI
44%
Loosely correlated
+0.97%
More